Cargando…
Specific associations between plasma biomarkers and postmortem amyloid plaque and tau tangle loads
Several promising plasma biomarkers for Alzheimer's disease have been recently developed, but their neuropathological correlates have not yet been fully determined. To investigate and compare independent associations between multiple plasma biomarkers (p‐tau181, p‐tau217, p‐tau231, Aβ42/40, GFA...
Autores principales: | Salvadó, Gemma, Ossenkoppele, Rik, Ashton, Nicholas J, Beach, Thomas G, Serrano, Geidy E, Reiman, Eric M, Zetterberg, Henrik, Mattsson‐Carlgren, Niklas, Janelidze, Shorena, Blennow, Kaj, Hansson, Oskar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10165361/ https://www.ncbi.nlm.nih.gov/pubmed/36912178 http://dx.doi.org/10.15252/emmm.202217123 |
Ejemplares similares
-
Untangling the association of amyloid-β and tau with synaptic and axonal loss
in Alzheimer’s disease
por: Pereira, Joana B, et al.
Publicado: (2020) -
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
por: Cicognola, Claudia, et al.
Publicado: (2021) -
Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
por: Mattsson‐Carlgren, Niklas, et al.
Publicado: (2021) -
Tau PET correlates with different Alzheimer’s disease‐related features compared to CSF and plasma p‐tau biomarkers
por: Ossenkoppele, Rik, et al.
Publicado: (2021) -
Plasma GFAP is an early marker of amyloid-β but not tau pathology in Alzheimer’s disease
por: Pereira, Joana B, et al.
Publicado: (2021)